Integra Lifesciences Holdings (IART) Interest Expenses (2009 - 2026)

Integra Lifesciences Holdings' Interest Expenses history runs 18 years deep, the most recent figure standing at $22.5 million for Q1 2026.

• In Q1 2026, Interest Expenses rose 19.4% year-over-year to $22.5 million; the TTM figure through Mar 2026 stood at $89.9 million (up 18.57% YoY), while the FY2025 annual figure was $86.3 million, up 22.12% from the prior year.
• Interest Expenses came in at $22.5 million for Q1 2026 at Integra Lifesciences Holdings, down from $23.7 million in the prior quarter.
• In the past five years, Interest Expenses ranged from a high of $23.7 million in Q4 2025 to a low of $11.7 million in Q1 2022.
• A 5-year average of $16.5 million and a median of $13.8 million in 2023 frame the typical range for Interest Expenses.
• Across the five-year window, Interest Expenses dropped 9.85% in 2022 and surged 49.64% in 2024, its largest moves.
• Integra Lifesciences Holdings' Interest Expenses stood at $12.9 million in 2022, then climbed by 6.65% to $13.8 million in 2023, then soared by 38.06% to $19.0 million in 2024, then climbed by 24.7% to $23.7 million in 2025, then retreated by 5.1% to $22.5 million in 2026.
• According to Business Quant data, Interest Expenses over the past three periods registered $22.5 million, $23.7 million, and $22.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison